159 related articles for article (PubMed ID: 7832221)
1. Lens changes after proton beam irradiation for uveal melanoma.
Gragoudas ES; Egan KM; Walsh SM; Regan S; Munzenrider JE; Taratuta V
Am J Ophthalmol; 1995 Feb; 119(2):157-64. PubMed ID: 7832221
[TBL] [Abstract][Full Text] [Related]
2. The Lens Opacities Classification System III Grading in Irradiated Uveal Melanomas to Characterize Proton Therapy-Induced Cataracts.
Mathis T; Rosier L; Meniai F; Baillif S; Maschi C; Herault J; Caujolle JP; Kodjikian L; Salleron J; Thariat J
Am J Ophthalmol; 2019 May; 201():63-71. PubMed ID: 30721686
[TBL] [Abstract][Full Text] [Related]
3. Cataract development in patients treated with proton beam therapy for uveal melanoma.
Seibel I; Cordini D; Hager A; Riechardt AI; Rehak M; Böker A; Böhmer D; Heufelder J; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1625-1630. PubMed ID: 27116211
[TBL] [Abstract][Full Text] [Related]
4. Anterior segment complications after helium ion radiation therapy for uveal melanoma. Radiation cataract.
Meecham WJ; Char DH; Kroll S; Castro JR; Blakely EA
Arch Ophthalmol; 1994 Feb; 112(2):197-203. PubMed ID: 8311772
[TBL] [Abstract][Full Text] [Related]
5. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications.
Pagliara MM; Tagliaferri L; Azario L; Lenkowicz J; Lanza A; Autorino R; Caputo CG; Gambacorta MA; Valentini V; Blasi MA
Brachytherapy; 2018; 17(2):432-438. PubMed ID: 29275868
[TBL] [Abstract][Full Text] [Related]
6. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
Puusaari I; Heikkonen J; Kivelä T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
Mishra KK; Daftari IK; Weinberg V; Cole T; Quivey JM; Castro JR; Phillips TL; Char DH
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):330-6. PubMed ID: 23886415
[TBL] [Abstract][Full Text] [Related]
8. Helium-ion-induced human cataractogenesis.
Blakely EA; Daftari IK; Meecham WJ; Alonso LC; Collier JM; Kroll SM; Gillette EL; Lee AC; Lett JT; Cox AB; Castro JR; Char DH
Adv Space Res; 1994 Oct; 14(10):501-5. PubMed ID: 11539986
[TBL] [Abstract][Full Text] [Related]
9. Cataract Avoidance With Proton Therapy in Ocular Melanomas.
Thariat J; Jacob S; Caujolle JP; Maschi C; Baillif S; Angellier G; Mathis T; Rosier L; Carnicer A; Hérault J; Salleron J
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5378-5386. PubMed ID: 29049739
[TBL] [Abstract][Full Text] [Related]
10. Lenticular opacities in individuals exposed to ionizing radiation in infancy.
Hall P; Granath F; Lundell M; Olsson K; Holm LE
Radiat Res; 1999 Aug; 152(2):190-5. PubMed ID: 10409329
[TBL] [Abstract][Full Text] [Related]
11. Cataractogenesis after Cobalt-60 eye plaque radiotherapy.
Kleineidam M; Augsburger JJ; Hernandez C; Glennon P; Brady LW
Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):625-30. PubMed ID: 8330992
[TBL] [Abstract][Full Text] [Related]
12. Plaque radiation therapy for malignant melanoma of the iris and ciliary body.
Finger PT
Am J Ophthalmol; 2001 Sep; 132(3):328-35. PubMed ID: 11530044
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for cataract after palladium-103 ophthalmic plaque radiation therapy.
Finger PT; Chin KJ; Yu GP; Patel NS;
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):800-6. PubMed ID: 20615627
[TBL] [Abstract][Full Text] [Related]
14. Ocular complications after iodine brachytherapy for large uveal melanomas.
Puusaari I; Heikkonen J; Kivelä T
Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
[TBL] [Abstract][Full Text] [Related]
15. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
[TBL] [Abstract][Full Text] [Related]
16. Radiation dose to the lens and cataract formation.
Henk JM; Whitelocke RA; Warrington AP; Bessell EM
Int J Radiat Oncol Biol Phys; 1993 Apr; 25(5):815-20. PubMed ID: 8478231
[TBL] [Abstract][Full Text] [Related]
17. Posterior uveal melanoma in young patients treated with proton beam therapy.
Vavvas D; Kim I; Lane AM; Chaglassian A; Mukai S; Gragoudas E
Retina; 2010 Sep; 30(8):1267-71. PubMed ID: 20224468
[TBL] [Abstract][Full Text] [Related]
18. Intraocular inflammation after proton beam irradiation for uveal melanoma.
Lumbroso L; Desjardins L; Levy C; Plancher C; Frau E; D'Hermies F; Schlienger P; Mammar H; Delacroix S; Nauraye C; Ferrand R; Desblancs C; Mazal A; Asselain B
Br J Ophthalmol; 2001 Nov; 85(11):1305-8. PubMed ID: 11673294
[TBL] [Abstract][Full Text] [Related]
19. Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma.
Summanen P; Immonen I; Kivelä T; Tommila P; Heikkonen J; Tarkkanen A
Br J Ophthalmol; 1996 Aug; 80(8):732-9. PubMed ID: 8949719
[TBL] [Abstract][Full Text] [Related]
20. Eye Lens Opacities Among Physicians Occupationally Exposed to Ionizing Radiation.
Auvinen A; Kivelä T; Heinävaara S; Mrena S
Ann Occup Hyg; 2015 Aug; 59(7):945-8. PubMed ID: 25868644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
